Authors: Llerena, A Berecz, R Norberto, MJ de la Rubia, A

Citation: A. Llerena et al., Determination of clozapine and its N-desmethyl metabolite by high-performance liquid chromatography with ultraviolet detection, J CHROMAT B, 755(1-2), 2001, pp. 349-354

Authors: Llerena, A Berecz, R de la Rubia, A Fernandez-Salguero, P Dorado, P

Citation: A. Llerena et al., Effect of thioridazine dosage on the debrisoquine hydroxylation phenotype in psychiatric patients with different CYP2D6 genotypes, THER DRUG M, 23(6), 2001, pp. 616-620

Authors: de la Rubia, A Arriaga, F Andreu, R Sanz, G Jimenez, C Vicente, A Carpio, N Marty, ML Sanz, MA

Citation: A. De La Rubia et al., Development of non-ABO RBC alloantibodies in patients undergoing allogeneic HPC transplantation. Is ABO incompatibility a predisposing factor?, TRANSFUSION, 41(1), 2001, pp. 106-110

Authors: Berecz, R Glaub, T Kellermann, M de la Rubia, A Llerena, A Degrell, I

Citation: R. Berecz et al., Clozapine withdrawal symptoms after change to sertindole in a schizophrenic patient, PHARMACOPS, 33(1), 2000, pp. 42-44

Authors: Llerena, A Berecz, R de la Rubia, A Norberto, MJ Benitez, J

Citation: A. Llerena et al., Use of the mesoridazine/thioridazine ratio as a marker for CYP2D6 enzyme activity, THER DRUG M, 22(4), 2000, pp. 397-401